Predictably, Congress couldn’t overturn President Bush’s veto of legislation that would have expanded federal funding for embryonic stem cell research.
That is unfortunate for all of the reasons that have been stated in the long debate over whether the United States will ever get serious about identifying the viable treatments for Parkinson’s disease, Alzheimer’s disease, spinal cord injuries, diabetes, strokes and burns that might well be found on the stem cell frontier.